We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Simple Fecal Blood Test Could Reduce Unnecessary Endoscopies

By HospiMedica International staff writers
Posted on 04 Oct 2016
Print article
Image: A simple fecal test can reduce the need for endoscopy (Photo courtesy of University Medical Center Utrecht).
Image: A simple fecal test can reduce the need for endoscopy (Photo courtesy of University Medical Center Utrecht).
A new diagnostic strategy for patients with suspected serious colorectal disease (SCD) could reduce the need for endoscopy by nearly a third, according to a new study.

Researchers at University Medical Center Utrecht (UMCU; The Netherlands), Gelderse Vallei Hospital (Ede, The Netherlands) and other hospitals across the Netherlands conducted a cross-sectional diagnostic study of 810 patients with suspected SCD referred by 266 primary general practitioner (GP) practices for endoscopy; all of the patients underwent a fecal immunochemical test (FIT), which uses an antibody that recognizes human hemoglobin, and so can be used to detect the presence of blood in a patients stool sample.

The results showed that out of the 810 patients referred for an endoscopy, 669 had no SCD. Once the results of the FIT test were taken into account, the researchers found that approximately 30% of these patients could have been prevented from having an endoscopy at all, as they may have been correctly diagnosed as not having SCD during their clinical visit. The researchers also examined the benefit of adding a fecal calprotectin (FCal) test to the diagnostic strategy; while this test did improve the diagnosis of SCD, it was not to the same extent as FIT. The study was published on September 26, 2016, in BMC Medicine.

“The amount of patients that are unnecessarily referred for an endoscopy strains health care budgets and exposes patients to a small but realistic risk from endoscopy associated complications,” said lead author Sjoerd Elias, MD, of UMCU, and colleagues. “Our study found that using a test called FIT, which detects the presence of hemoglobin in the patient's feces, alongside the usual diagnostic work up done by GPs could rule out nearly a third of patients from requiring an endoscopy to check for SCD.”

SCD, which includes colorectal cancer, is difficult to diagnose as the signs and symptoms are not always clear. Any suspicion of SCD requires a GP referral to a hospital for an endoscopy, but numerous studies have shown that between 60-80% of referred patients end up not having SCD.

Related Links:
University Medical Center Utrecht
Gelderse Vallei Hospital
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Oxidized Zirconium Implant Material
OXINIUM

Print article

Channels

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.